Torrent Pharma trades near key resistance at ₹3,600, with a breakout on strong volume likely triggering a fresh rally, says SEBI-registered analyst Mayank Singh Chandel. The stock remains above its 200-day EMA. Acquisition of JB Chemicals for ₹19,500 crore awaits regulatory approval. Q1 earnings on July 28 and deal updates could act as near-term catalysts.